Kelly Lawrence W & Associates’s Amgen AMGN Stock Holding History

Kelly Lawrence W & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$492K	Hold	1,398	–	–	0.14%	61
2025 Q4	$458K	Hold	1,398	–	–	0.11%	60
2025 Q3	$395K	Hold	1,398	–	–	0.1%	65
2025 Q2	$390K	Sell	1,398 -353	-20%	-$100K	0.1%	59
2025 Q1	$546K	Hold	1,751	–	–	0.13%	54
2024 Q4	$456K	Hold	1,751	–	–	0.11%	57
2024 Q3	$564K	Sell	1,751 -75	-4%	-$24.5K	0.13%	56
2024 Q2	$571K	Hold	1,826	–	–	0.13%	55
2024 Q1	$519K	Hold	1,826	–	–	0.12%	55
2023 Q4	$526K	Hold	1,826	–	–	0.13%	56
2023 Q3	$491K	Hold	1,826	–	–	0.13%	56
2023 Q2	$417K	Sell	1,826 -90	-5%	-$20.9K	0.11%	63
2023 Q1	$463K	Hold	1,916	–	–	0.13%	58
2022 Q4	$503K	Sell	1,916 -284	-13%	-$76.1K	0.14%	54
2022 Q3	$496K	Buy	2,200 +70	+3%	+$17K	0.14%	60
2022 Q2	$518K	Hold	2,130	–	–	0.14%	56
2022 Q1	$515K	Sell	2,130 -840	-28%	-$193K	0.11%	57
2021 Q4	$668K	Sell	2,970 -300	-9%	-$63.3K	0.13%	51
2021 Q3	$696K	Hold	3,270	–	–	0.15%	51
2021 Q2	$797K	Hold	3,270	–	–	0.17%	50
2021 Q1	$813K	Buy	3,270 +1,043	+47%	+$249K	0.19%	49
2020 Q4	$512K	Sell	2,227 -1,575	-41%	-$363K	0.2%	42
2020 Q3	$966K	Hold	3,802	–	–	0.29%	38
2020 Q2	$897K	Buy	3,802 +40	+1%	+$9.13K	0.19%	40
2020 Q1	$762K	Hold	3,762	–	–	0.19%	43
2019 Q4	$907K	Hold	3,762	–	–	0.14%	50
2019 Q3	$728K	Hold	3,762	–	–	0.12%	52
2019 Q2	$693K	Hold	3,762	–	–	0.12%	53
2019 Q1	$715K	Hold	3,762	–	–	0.13%	55
2018 Q4	$733K	Sell	3,762 -1,701	-31%	-$332K	0.16%	53
2018 Q3	$1.13M	Buy	5,463 +300	+6%	+$59.1K	0.19%	52
2018 Q2	$953K	Sell	5,163 -300	-5%	-$53.1K	0.18%	53
2018 Q1	$931K	Sell	5,463 -30	-0.5%	-$5.51K	0.18%	51
2017 Q4	$955K	Buy	5,493 +145	+3%	+$25.7K	0.18%	52
2017 Q3	$997K	Buy	5,348 +125	+2%	+$22.1K	0.19%	53
2017 Q2	$900K	Hold	5,223	–	–	0.18%	53
2017 Q1	$857K	Buy	5,223 +151	+3%	+$25.1K	0.18%	53
2016 Q4	$742K	Sell	5,072 -30,700	-86%	-$4.62M	0.16%	54
2016 Q3	$5.97M	Hold	35,772	–	–	1.28%	34
2016 Q2	$5.44M	Hold	35,772	–	–	1.26%	32
2016 Q1	$5.36M	Buy	35,772 +1,020	+3%	+$152K	1.34%	29
2015 Q4	$5.64M	Buy	34,752 +26,090	+301%	+$4.1M	1.28%	32
2015 Q3	$1.2M	Buy	8,662 +3,600	+71%	+$567K	0.28%	46
2015 Q2	$777K	Buy	5,062 +4,900	+3,025%	+$785K	0.15%	52
2015 Q1	$26K	Hold	162	–	–	0.01%	106
2014 Q4	$26K	Buy	+162	New	+$25.2K	0.01%	110
2014 Q3	–	Sell	-162	Closed	-$19K	–	85
2014 Q2	$19K	Hold	162	–	–	﹤0.01%	114
2014 Q1	$20K	Buy	162 +62	+62%	+$7.52K	﹤0.01%	110
2013 Q4	$11K	Buy	+100	New	+$11.4K	﹤0.01%	115
2013 Q3	–	Sell	-100	Closed	-$10K	–	81
2013 Q2	$10K	Buy	+100	New	+$10.4K	﹤0.01%	107

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Kelly Lawrence W & Associates's AMGN Position: Q1 2026 in Review

Kelly Lawrence W & Associates held its Amgen (AMGN) position steady in Q1 2026 at 1,398 shares worth $492K. The position accounts for 0.14% of the portfolio, ranked #61.

Kelly Lawrence W & Associates first reported a position in AMGN in Q2 2013 and has held it in 50 quarters since. The position peaked at $5.97M in Q3 2016. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Kelly Lawrence W & Associates held 1,398 shares of Amgen worth $492K as of Q1 2026.
Kelly Lawrence W & Associates left its Amgen share count unchanged in Q1 2026.
Amgen made up 0.14% of Kelly Lawrence W & Associates's portfolio in Q1 2026, its #61 holding.
Kelly Lawrence W & Associates first reported a position in Amgen in Q2 2013 and has held it in 50 quarters since.
Kelly Lawrence W & Associates's Amgen position peaked at $5.97M in Q3 2016.
3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Kelly Lawrence W & Associates's 13F filing for Q1 2026, filed 15 May 2026.